These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37062414)

  • 1. LC/MS Assessment of Glycoform Clearance of A Biotherapeutic MAb in Rabbit Ocular Tissues.
    Dong S; Chen L; Sauer A; Dittus L
    J Pharm Sci; 2023 Aug; 112(8):2285-2291. PubMed ID: 37062414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody.
    Falck D; Thomann M; Lechmann M; Koeleman CAM; Malik S; Jany C; Wuhrer M; Reusch D
    MAbs; 2021; 13(1):1865596. PubMed ID: 33382957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of therapeutic antibody glycoforms after subcutaneous and intravenous injection in a porcine model.
    Falck D; Lechmann M; Momčilović A; Thomann M; Koeleman CAM; Jany C; Malik S; Wuhrer M; Reusch D
    MAbs; 2022; 14(1):2145929. PubMed ID: 36383465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacokinetics of a recombinant humanized rabbit anti-VEGF monoclonal antibody in rabbits and monkeys.
    Yu DA; You M; Ji WW; Lu Y; Liu B; Yan SS
    Toxicol Lett; 2018 Aug; 292():73-77. PubMed ID: 29709424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular pharmacokinetics of fluocinolone acetonide following Iluvien implantation in the vitreous humor of rabbits.
    Kane FE; Green KE
    J Ocul Pharmacol Ther; 2015 Feb; 31(1):11-6. PubMed ID: 25562126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid evaluation for heterogeneities in monoclonal antibodies by liquid chromatography/mass spectrometry with a column-switching system.
    Kuribayashi R; Hashii N; Harazono A; Kawasaki N
    J Pharm Biomed Anal; 2012; 67-68():1-9. PubMed ID: 22579601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular silicon distribution and clearance following intravitreal injection of porous silicon microparticles.
    Nieto A; Hou H; Sailor MJ; Freeman WR; Cheng L
    Exp Eye Res; 2013 Nov; 116():161-8. PubMed ID: 24036388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular metabolism and distribution of drugs in the rabbit eye: Quantitative assessment after intracameral and intravitreal administrations.
    Del Amo EM; Hammid A; Tausch M; Toropainen E; Sadeghi A; Valtari A; Puranen J; Reinisalo M; Ruponen M; Urtti A; Sauer A; Honkakoski P
    Int J Pharm; 2022 Feb; 613():121361. PubMed ID: 34896561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and pharmacokinetics of intravitreal sirolimus.
    Mudumba S; Bezwada P; Takanaga H; Hosoi K; Tsuboi T; Ueda K; Kawazu K; Ali Y; Naor J
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):507-14. PubMed ID: 22662868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a potential human cytomegalovirus therapeutic, a phosphorothioate oligonucleotide, after intravitreal injection in the rabbit.
    Leeds JM; Henry SP; Truong L; Zutshi A; Levin AA; Kornbrust D
    Drug Metab Dispos; 1997 Aug; 25(8):921-6. PubMed ID: 9280399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular pharmacokinetics profile of different indomethacin topical formulations.
    Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Melphalan After Intravitreal Injection in a Rabbit Model.
    Buitrago E; Winter U; Williams G; Asprea M; Chantada G; Schaiquevich P
    J Ocul Pharmacol Ther; 2016 May; 32(4):230-5. PubMed ID: 26785130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach for the simultaneous quantification of a therapeutic monoclonal antibody in serum produced from two distinct host cell lines.
    Geist BJ; Davis D; McIntosh T; Yang TY; Goldberg K; Han C; Pendley C; Davis HM
    MAbs; 2013; 5(1):150-61. PubMed ID: 23182963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometry.
    Woodall DW; Dillon TM; Kalenian K; Padaki R; Kuhns S; Semin DJ; Bondarenko PV
    MAbs; 2022; 14(1):2004982. PubMed ID: 34978527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast and Ultrasensitive Glycoform Analysis by Supercritical Fluid Chromatography-Tandem Mass Spectrometry.
    Haga Y; Yamada M; Fujii R; Saichi N; Yokokawa T; Hama T; Hayakawa Y; Ueda K
    Anal Chem; 2022 Nov; 94(46):15948-15955. PubMed ID: 36345688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended Pharmacokinetic Model of the Intravitreal Injections of Macromolecules in Rabbits. Part 2: Parameter Estimation Based on Concentration Dynamics in the Vitreous, Retina, and Aqueous Humor.
    Lamminsalo M; Karvinen T; Subrizi A; Urtti A; Ranta VP
    Pharm Res; 2020 Oct; 37(11):226. PubMed ID: 33094404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular pharmacokinetics of intravitreally administered brimonidine and dexamethasone in animal models with and without blood-retinal barrier breakdown.
    Shen J; Durairaj C; Lin T; Liu Y; Burke J
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1056-66. PubMed ID: 24448267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS.
    Bisht R; Mandal A; Rupenthal ID; Mitra AK
    Drug Deliv Transl Res; 2016 Dec; 6(6):763-770. PubMed ID: 27371395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Mechanistic Model of the Intravitreal Pharmacokinetics of Large Molecules and the Pharmacodynamic Suppression of Ocular Vascular Endothelial Growth Factor Levels by Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration.
    Hutton-Smith LA; Gaffney EA; Byrne HM; Maini PK; Schwab D; Mazer NA
    Mol Pharm; 2016 Sep; 13(9):2941-50. PubMed ID: 26726925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different intravitreal properties of three triamcinolone formulations and their possible impact on retina practice.
    Chen H; Sun S; Li J; Du W; Zhao C; Hou J; Xu Y; Cheng L
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2178-85. PubMed ID: 23449717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.